The Trendlines Group (TRNGF) Fair Value & Analysis
Financial Services · US · Market cap $42.4M
Fair value as of: Jun 26, 2026
Analysis
The Trendlines Group (TRNGF) currently trades at $0.0291, while our model-based Fair Value estimate is $0.0265 — implying the stock looks roughly 9.1% overvalued today. We read business quality at 94/100 (high quality), in the Financial Services sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
About the company
The Trendlines Group Ltd. is an innovation commercialization company and a private equity and venture capital firm specializing in incubation, seed, start-up, early venture and late venture investments. The firm seeks to invest in food, medtech, clean technology, agrifood, agritechnology, healthcare, life sciences, with a focus on medical devices, biotechnology, and pharmaceuticals, security, medical, and information technology companies. It considers investments in Israel and Singapore. The firm offers business incubation, partner and channel development, market strategies, business plans, research and development and commercialization activities, business development, finance and funding strategies, administrative services and marketing communications services to entrepreneurs. The firm prefers to exit its investments through merger and acquisition transactions, listing on public stock exchanges, or other dispositions of holdings. It leverages its own capital with government fundi…
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is The Trendlines Group (TRNGF) undervalued?
What is the fair value of TRNGF?
What is the quality score of TRNGF?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.